FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Mult… (NCT07446777) | Clinical Trial Compass
RecruitingNot Applicable
FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease
United States120 participantsStarted 2026-04-07
Plain-language summary
The purpose of this study is to find out whether a dietary approach that includes prolonged overnight fasting, guided by a Mediterranean-style eating pattern, is feasible for patients with myeloma precursor disease or newly diagnosed multiple myeloma.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. 18 years of age or older.
✓. Any sex/gender.
✓. Able to provide consent.
✓. Able to speak, read, and understand English or Spanish.
✓. Diagnosis of Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM), or Multiple Myeloma (MM) per standard criteria:
✓. Cohort 1 - Participants must have a confirmed diagnosis of MGUS and SMM.
✓. Cohort 2 - Participants must have a confirmed new diagnosis of MM and be initiating anti-myeloma therapy.
✓. Delivery of anti-myeloma therapies at one of the following institutions:
Exclusion criteria
✕. Individuals younger than 18 years of age.
✕. Unable to provide consent.
✕. Unable to read or understand English or Spanish.
✕. Any contraindication for diet changes as determined by physician.
✕. History of a clinical eating disorder.
✕. History of dementia or major psychiatric disease.
What they're measuring
1
Feasibility: Percentage of Participants That Agree to Participate
Timeframe: Baseline
2
Retention Rate Among Participants Assigned to the Intervention Arm